Innovative Treatment Centers

Innovative Treatment Centers in Glen Burnie, Maryland offers Spravato (esketamine), an FDA-approved treatment for adults with treatment-resistant depression and major depressive disorder with suicidal thoughts. Administered as a nasal spray under medical supervision, Spravato targets the NMDA receptor in the brain and can rapidly reduce depressive symptoms, sometimes within hours or days.

Patients may be candidates if they have tried two or more antidepressants without success or continue to experience persistent depressive symptoms. The clinic conducts a comprehensive psychiatric assessment and coordinates with existing providers to determine whether Spravato is the right path forward.

Spravato is covered by most major insurance plans and delivered in a safe, monitored setting. ITC also offers diagnostic assessments, therapy, addiction medicine with medication-assisted treatment, case management, and ADHD assessments.